pI: 8.6301 |
Length (AA): 190 |
MW (Da): 21576 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 3 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
1 | 189 | 1wpx (B) | 507 | 717 | 24.00 | 0 | 1 | 1.25 | -0.81 |
4 | 188 | 2gzq (A) | 5 | 189 | 74.00 | 0 | 1 | 2.03 | -2.21 |
3 | 189 | 2r77 (A) | 19 | 205 | 99.99 | 0 | 1 | 2.27421 | -2 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Resolution | Method | # Atoms | # Residues | Dep. Date | Pub. Date | Mod. Date |
---|---|---|---|---|---|---|
Resolution | Method | # Atoms | # Residues | Dep. Date | Pub. Date | Mod. Date |
---|---|---|---|---|---|---|
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
NA% percentile | intra-erythrocytic - 0 hs, intra-erythrocytic - 32 hs. | Otto TD |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 60-80% percentile | Sporozoite. | Zanghi G |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Mid 40-60% percentile | intra-erythrocytic - 24 hs. | Otto TD |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Lower 20-40% percentile | intra-erythrocytic - 8 hs, intra-erythrocytic - 16 hs, Oocyst, Ring, Female Gametocyte. | Otto TD Zanghi G Lasonder E |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Lower 0-20% percentile | intra-erythrocytic - 40 hs, intra-erythrocytic - 48 hs, Male Gametocyte. | Otto TD Lasonder E |
Otto TD | New insights into the blood-stage transcriptome of Plasmodium falciparum using RNA-Seq. |
Zanghi G | A Specific PfEMP1 Is Expressed in P. falciparum Sporozoites and Plays a Role in Hepatocyte Infection. |
Lasonder E | Integrated transcriptomic and proteomic analyses of P. falciparum gametocytes. Molecular insight into sex-specific processes and translational repression. |
Ortholog group members (OG5_127642)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT1G18100 | protein MOTHER of FT and TF 1 |
Brugia malayi | Bm1_41005 | OV-16 antigen precursor |
Candida albicans | CaO19.9530 | putative lipid binding protein |
Candida albicans | CaO19.1974 | cell cycle regulator |
Caenorhabditis elegans | CELE_F40A3.3 | Protein F40A3.3, isoform B |
Dictyostelium discoideum | DDB_G0283803 | phosphatidylethanolamine-binding protein PEBP |
Drosophila melanogaster | Dmel_CG17919 | CG17919 gene product from transcript CG17919-RA |
Drosophila melanogaster | Dmel_CG6180 | CG6180 gene product from transcript CG6180-RA |
Drosophila melanogaster | Dmel_CG10298 | CG10298 gene product from transcript CG10298-RA |
Homo sapiens | ENSG00000089220 | phosphatidylethanolamine binding protein 1 |
Loa Loa (eye worm) | LOAG_11720 | OV-16 antigen |
Mus musculus | 76400 | phosphatidylethanolamine binding protein 2 |
Mus musculus | ENSMUSG00000032959 | phosphatidylethanolamine binding protein 1 |
Neospora caninum | NCLIV_002850 | hypothetical protein |
Oryza sativa | 4326145 | Os01g0111600 |
Oryza sativa | 4341107 | Os06g0498800 |
Oryza sativa | 4341272 | Os06g0552900 |
Plasmodium berghei | PBANKA_1434900 | raf kinase inhibitor, putative |
Plasmodium falciparum | PF3D7_1219700 | raf kinase inhibitor |
Plasmodium knowlesi | PKNH_1438900 | raf kinase inhibitor, putative |
Plasmodium vivax | PVX_123630 | raf kinase inhibitor, putative |
Plasmodium vivax | PVX_235290 | unspecified product |
Plasmodium yoelii | PY01852 | putative phosphatidylethanolamine-binding protein |
Saccharomyces cerevisiae | YLR179C | hypothetical protein |
Saccharomyces cerevisiae | YLR178C | Tfs1p |
Toxoplasma gondii | TGME49_207930 | phosphatidylethanolamine-binding protein |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
TGME49_207930 | Toxoplasma gondii | Essentiality uncertain | sidik |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Type | Source | Notes |
---|---|---|
soluble recombinant protein | Structural Genomics for Pathogenic Protozoa (SGPP) | Pviv009166; Recombinant protein: full-length; Source: P vivax; Phosphatidylethanolamine-binding protein ; Identifier: Pv123630 |